P Bruggmann
Trends in hepatitis C-related mortality in Switzerland
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela D, Terziroli B, Bruggmann P, Moradpour D, Dufour J, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort. Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat 2017; 25:152-160.
20.11.2017Trends in hepatitis C-related mortality in Switzerland
20.11.2017J Viral Hepat 2017; 25:152-160
Keiser O, Spoerri A, Negro F, Estill J, Bertisch B, Brezzi M, Semela David, Terziroli B, Bruggmann P, Moradpour D, Dufour J-F, Junker C, Mullhaupt B, Giudici F, Swiss Hepatitis C Cohort Study and the Swiss National Cohort
Strategies to manage hepatitis C virus (HCV) disease burden
Kautz A, Myers R, Nemecek V, Øvrehus A, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Roberts S, Mullhaupt B, Moreno C, Mendes Correa M, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha G, Sperl J, Stärkel P, Stauber R, Thompson A, Gower E, Kaita K, Wedemeyer H, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Calinas F, Calleja J, Cheinquer H, Christensen P, Berg T, Balık I, Aleman S, Duberg A, Buti M, Rosenberg W, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H, Gerstoft J, Giria J, Gonçales F, Guimarães Pessôa M, Hézode C, Hindman S, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P, Ferraz M, Cornberg M, Cramp M, Dore G, Doss W, El-Sayed M, Ergör G, Estes C, Falconer K, Félix J, Kåberg M. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21 Suppl 1:60-89.
01.05.2014Strategies to manage hepatitis C virus (HCV) disease burden
01.05.2014J Viral Hepat 2014; 21 Suppl 1:60-89
Kautz A, Myers R P, Nemecek V, Øvrehus A L H, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Roberts S K, Mullhaupt B, Moreno C, Mendes Correa M C, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho R T, Marotta P, Mauss S, Roudot-Thoraval F, Ryder S D, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Sarrazin C, Semela David, Sherman M, Shiha G E, Sperl J, Stärkel P, Stauber R E, Thompson A J, Gower E, Kaita K D E, Wedemeyer H, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Berg T, Balık I, Aleman S, Duberg A S, Buti M, Rosenberg W M, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Clausen M, Coelho H S M, Gerstoft J, Giria J A, Gonçales F L, Guimarães Pessôa M, Hézode C, Hindman S J, Hofer H, Husa P, Idilman R, García-Samaniego J, Ferreira P R, Ferraz M L G, Cornberg M, Cramp M E, Dore G J, Doss W, El-Sayed M H, Ergör G, Estes C, Falconer K, Félix J, Kåberg M
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
Kaita K, Nemecek V, Örmeci N, Øvrehus A, Parkes J, Pasini K, Peltekian K, Ramji A, Reis N, Roberts S, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R, Marotta P, Mauss S, Rosenberg W, Roudot-Thoraval F, Ryder S, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela D, Sherman M, Shiha G, Sievert W, Sperl J, Stärkel P, Stauber R, Thompson A, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A, Brandão Mello C, Bruggmann P, Buti M, Calleja J, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R, Idilman R, Calinas F, Vogel W, Mendes Correa M, Hézode C, Lázaro P, Christensen P, Clausen M, Coelho H, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S, Hofer H, Frankova S, Ferreira P, Ferraz M, Cramp M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Falconer K, Félix J, Husa P. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat 2014; 21 Suppl 1:34-59.
01.05.2014The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
01.05.2014J Viral Hepat 2014; 21 Suppl 1:34-59
Kaita K D E, Nemecek V, Örmeci N, Øvrehus A L H, Parkes J, Pasini K, Peltekian K M, Ramji A, Reis N, Roberts S K, Negro F, Murphy K, Moreno C, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho R T, Marotta P, Mauss S, Rosenberg W M, Roudot-Thoraval F, Ryder S D, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Mullhaupt B, van Thiel I, Van Damme P, Urbanek P, Sarmento-Castro R, Semela David, Sherman M, Shiha G E, Sievert W, Sperl J, Stärkel P, Stauber R E, Thompson A J, Estes C, Kåberg M, Razavi H, Berg T, Bihl F, Bilodeau M, Blasco A J, Brandão Mello C E, Bruggmann P, Buti M, Calleja J L, Cheinquer H, Balık I, Aleman S, Akarca U, Waked I, Sarrazin C, Myers R P, Idilman R, Calinas F, Vogel W, Mendes Correa M C, Hézode C, Lázaro P, Christensen P B, Clausen M, Coelho H S M, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman S J, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Cramp M E, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Falconer K, Félix J, Husa P
Historical epidemiology of hepatitis C virus (HCV) in selected countries
Kåberg M, Myers R, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M, Mauss S, Kaita K, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S, Rosenberg W, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela D, Shiha G, Sievert W, Stärkel P, Stauber R, Thompson A, Urbanek P, Hindman S, Idilman R, Bruggmann P, Bilodeau M, Blasco A, Buti M, Calinas F, Calleja J, Cheinquer H, Christensen P, Clausen M, Coelho H, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A, Moreno C, Brandão Mello C, Roudot-Thoraval F, Marinho R, Sherman M, Ryder S, Sperl J, Cornberg M, Cramp M, García-Samaniego J, Gerstoft J, Giria J, Gonçales F, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P, Ferraz M, Dore G, Doss W, Duberg A, El-Sayed M, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat 2014; 21 Suppl 1:5-33.
01.05.2014Historical epidemiology of hepatitis C virus (HCV) in selected countries
01.05.2014J Viral Hepat 2014; 21 Suppl 1:5-33
Kåberg M, Myers R P, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian K M, Ramji A, Razavi H, Reis N, Mullhaupt B, Mendes Correa M C, Mauss S, Kaita K D E, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Roberts S K, Rosenberg W M, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Vandijck D, Van Vlierberghe H, van Thiel I, Sarmento-Castro R, Sarrazin C, Semela David, Shiha G E, Sievert W, Stärkel P, Stauber R E, Thompson A J, Urbanek P, Hindman S J, Idilman R, Bruggmann P, Bilodeau M, Blasco A J, Buti M, Calinas F, Calleja J L, Cheinquer H, Christensen P B, Clausen M, Coelho H S M, Bihl F, Balık I, Akarca U, Berg T, Øvrehus A L H, Moreno C, Brandão Mello C E, Roudot-Thoraval F, Marinho R T, Sherman M, Ryder S D, Sperl J, Cornberg M, Cramp M E, García-Samaniego J, Gerstoft J, Giria J A, Gonçales F L, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Frankova S, Ferreira P R, Ferraz M L G, Dore G J, Doss W, Duberg A S, El-Sayed M H, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Husa P
Management of hepatitis C virus (HCV) infection in drug substitution programs
Witteck A, Schmid P, Hensel-Koch K, Thurnheer M, Bruggmann P, Vernazza P. Management of hepatitis C virus (HCV) infection in drug substitution programs. Swiss Med Wkly 2011; 141:w13193.
27.05.2011Management of hepatitis C virus (HCV) infection in drug substitution programs
27.05.2011Swiss Med Wkly 2011; 141:w13193
Witteck Andrea, Schmid Patrick, Hensel-Koch K, Thurnheer M C, Bruggmann P, Vernazza Pietro